nVerses Capital »

Arcturus Therapeutics Hldg I shares owned by nVerses Capital

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by nVerses Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $140k 23k 6.13
2024-09-30 $42k 1.8k 23.21

More positions owned by nVerses Capital

Expedia Group Com New (EXPE)
NetApp (NTAP)
Sherwin-Williams Company (SHW)
Aurinia Pharmaceuticals (AUPH)
Alignment Healthcare (ALHC)
Adma Biologics (ADMA)
Equifax (EFX)
Marathon Petroleum Corp (MPC)
Pagseguro Digital Com Cl A (PAGS)
Freshworks Class A Com (FRSH)
Upwork (UPWK)
Centene Corporation (CNC)
Arista Networks Com Shs (ANET)
Verisign (VRSN)
Blackstone Group Inc Com Cl A (BX)

View all positions for nVerses Capital

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
BlackRock
ARK Investment Management
Balyasny Asset Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
State Street Corporation
Jane Street
Dimensional Fund Advisors
Acadian Asset Management
Empire Life Investments
Goldman Sachs Group
Jacobs Levy Equity Management

View all funds holding Arcturus Therapeutics Hldg I